Exane Derivatives’s ChargePoint CHPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CHPT
LC
BEVI
LCMP
SIMS
RCP
Exane Derivatives's CHPT Position: Q2 2022 in Review
Exane Derivatives increased its ChargePoint (CHPT) stake by 16% in Q2 2022, buying an estimated $76.5K and bringing the position to 1,967 shares worth $539K. The position accounts for 0.31% of the portfolio, ranked #76.
Exane Derivatives first reported a position in CHPT in Q2 2021 and has held it in 5 quarters since. The position peaked at $705K in Q3 2021. 364 funds tracked by Wall St. Rank hold CHPT as of Q2 2022.
- Exane Derivatives held 1,967 shares of ChargePoint worth $539K as of Q2 2022.
- Exane Derivatives bought 276 ChargePoint shares in Q2 2022, an estimated $76.5K.
- ChargePoint made up 0.31% of Exane Derivatives's portfolio in Q2 2022, its #76 holding.
- Exane Derivatives first reported a position in ChargePoint in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's ChargePoint position peaked at $705K in Q3 2021.
- 364 funds tracked by Wall St. Rank held ChargePoint as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.